Trial Details

COMPLETED
Basic Information
Clinical ID c4404
Identifier NCT00577473
Trial Title Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis
Interventions DRUG: mesalamine|DRUG: mesalamine
Participant Information
Sponsor Warner Chilcott
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2001-02
Primary Completion Date 2003-02
Completion Date 2003-02